These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 6612078)
41. Antivirals and influenza: frequency of resistance. Monto AS Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569 [TBL] [Abstract][Full Text] [Related]
42. ACIP issues recommendations for the prevention and control of influenza in the 1996-97 season. Am Fam Physician; 1996 Aug; 54(2):767-70, 773-4. PubMed ID: 8701846 [No Abstract] [Full Text] [Related]
43. ACIP updates recommendations for the use of antiviral agents in influenza. Advisory Committee on Immunization Practices. Am Fam Physician; 1995 Aug; 52(2):659-60, 663. PubMed ID: 7625333 [No Abstract] [Full Text] [Related]
44. Antiviral drugs for prophylaxis and treatment of influenza. Obstet Gynecol; 2005 Feb; 105(2):427-9. PubMed ID: 15684174 [No Abstract] [Full Text] [Related]
45. Updated treatment for influenza A and B. Montalto NJ; Gum KD; Ashley JV Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232 [TBL] [Abstract][Full Text] [Related]
46. Rimantadine for prevention and treatment of influenza. Med Lett Drugs Ther; 1993 Nov; 35(910):109-10. PubMed ID: 8232065 [No Abstract] [Full Text] [Related]
47. Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine. Millet VM; Dreisbach M; Bryson YJ Antimicrob Agents Chemother; 1982 Jan; 21(1):1-4. PubMed ID: 7044294 [TBL] [Abstract][Full Text] [Related]
48. Antiviral therapy and prophylaxis for influenza in children. American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862 [TBL] [Abstract][Full Text] [Related]
49. The importance of virus drug-resistance in the treatment of influenza with rimantadine. Kubar OI; Brjantseva EA; Nikitina LE; Zlydnikov DM Antiviral Res; 1989; 11(5-6):313-5. PubMed ID: 2802572 [TBL] [Abstract][Full Text] [Related]
54. Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective. Guay DR Drugs Aging; 1994 Jul; 5(1):8-19. PubMed ID: 7919641 [TBL] [Abstract][Full Text] [Related]
55. [Rimantadine in the prevention and treatment of influenza A]. Hannoun C Rev Med Interne; 1988; 9(5):554-8. PubMed ID: 3067304 [TBL] [Abstract][Full Text] [Related]
56. HHS-CDC NEWS: update: influenza activity--US and worldwide, 2005-2006 season, and composition of the 2006-2007 influenza vaccine. Ann Pharmacother; 2006; 40(7-8):1499-500. PubMed ID: 16849615 [No Abstract] [Full Text] [Related]
57. Long-term stability of the anti-influenza A compounds--amantadine and rimantadine. Scholtissek C; Webster RG Antiviral Res; 1998 Jun; 38(3):213-5. PubMed ID: 9754890 [TBL] [Abstract][Full Text] [Related]
58. [Effect of amantadine (1-aminoadamantane) and remantadine (alpha-methyl-1-adamantane methyl amine) hydrochlorides on formation of influenza A viral proteins]. Galegov GA; Vladyko AS; Linitskaia GL; Shobukhov VM Vopr Med Khim; 1981; 27(2):251-4. PubMed ID: 7281566 [TBL] [Abstract][Full Text] [Related]